Podcast Episodes
Back to SearchNov 07, 2025 This Week in Cardiology
Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, an…
7 months, 2 weeks ago
Oct 31 2025 This Week in Cardiology
Four pillars of cardiology today, stable coronary artery disease, severe aortic stenosis, the evaluation of chest pain, and best therapies for atrial…
7 months, 3 weeks ago
Oct 24 2025 This Week in Cardiology
The PREVENT score in hypertension, GLP-1 mechanism of action in cardiovascular disease, CAD type and statin benefit, and the problem with hospitaliza…
8 months ago
Oct 17 2025 This Week in Cardiology
Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical exam of the future, and the problem of underpowered trials …
8 months, 1 week ago
Oct 10 2025 This Week in Cardiology
GLP-1 use in HFrEF, left atrial posterior wall isolation during AF ablation, peri-device leaks for LAAO, new findings in post-cardiac surgery AF, and…
8 months, 2 weeks ago
Oct 03 2025 This Week in Cardiology
Two great stories of translation science leading to beneficial drugs in terrible diseases of the heart and the Sisyphean task of predicting the need …
8 months, 3 weeks ago
Sep 26 2025 This Week in Cardiology
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and …
9 months ago
Sep 19 2025 This Week in Cardiology
More trials at ESC, including PARACHUTE HF, DAPA ACT HF-TIMI 68, AMALFI, and a super-interesting modeling study of when to start oral anticoagulants …
9 months, 1 week ago
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed …
9 months, 2 weeks ago
Sep 05 2025 This Week in Cardiology
The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping OAC after successful AF ablation, and DANCAVAS II trial are …
9 months, 3 weeks ago